You have 9 free searches left this month | for more free features.

toripalimab

Showing 1 - 25 of 139

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)

Recruiting
  • Esophageal Carcinoma
  • toripalimab
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Aug 20, 2023

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 9, 2023

Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    hongshan Hospital Affiliated to Fudan University
Sep 14, 2023

Solid Tumor Trial in Changchun (WX390, Toripalimab)

Recruiting
  • Solid Tumor
  • Changchun, Jilin, China
    the first affiliated hospital of Jilin university
Nov 3, 2023

Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Toripalimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Apr 2, 2023

Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

Recruiting
  • Cervical Cancer
  • +2 more
  • Toripalimab
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Oct 16, 2023

NSCLC Trial in Shanghai (Toripalimab, Cryoablation)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Toripalimab
  • Cryoablation
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 7, 2023

Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)

Recruiting
  • Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
  • Shanghai, Shanghai, China
    The Obstetrics & Gynecology Hospital of Fudan University (Shangh
Nov 3, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 19, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • Toripalimab
  • +3 more
  • (no location specified)
Aug 16, 2023

Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)

Not yet recruiting
  • Head and Neck Cancer
  • +9 more
  • (no location specified)
Jul 12, 2023

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Toripalimab
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

Recruiting
  • NSCLC
  • SBRT+LDRT
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Apr 2, 2023

Local Advanced NSCLC Trial (Toripalimab, Radical thoracic radiotherapy)

Not yet recruiting
  • Local Advanced Non-small Cell Lung Cancer
  • Toripalimab
  • Radical thoracic radiotherapy
  • (no location specified)
Jun 2, 2023

Rectal Cancer Trial in Chengdu (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Mar 8, 2023

Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)

Recruiting
  • Lung Cancer
  • Toripalimab
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Dec 7, 2022

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Toripalimab
  • (no location specified)
Mar 20, 2023

Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced
  • +3 more
  • Toripalimab
  • +3 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital Southern Medical University
May 17, 2023

Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Toripalimab
  • Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Apr 5, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 1, 2023

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 7, 2023

Esophageal Squamous Cell Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)

Recruiting
  • Esophageal Squamous Cell Cancer
  • Toripalimab
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023